This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer.

Clinical trial NCT07309887 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07309887
Sponsor: Samsung Medical Center
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Early Breast Cancer

Start date: 2025-12-17
Primary completion: 2026-01-31
Enrollment: 100000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.